(HBI) Hanesbrands - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4103451021
HBI: Underwear, Socks, Bras, Shapewear, T-Shirts, Fleece, Activewear
Hanesbrands Inc. (NYSE:HBI) stands as a cornerstone in the consumer goods sector, specializing in the design, manufacturing, and distribution of innerwear and activewear. With a legacy dating back to 1901, the company has carved out a significant presence in the Americas, Europe, Asia-Pacific, and beyond. Its operations are neatly divided into three segments: Innerwear, Activewear, and International, each contributing to a diverse portfolio that meets the everyday needs of consumers.
The companys product lineup is both extensive and essential, encompassing mens underwear, womens panties, childrens underwear, and socks, alongside intimate apparel such as bras and shapewear. Their activewear range includes T-shirts, fleece, performance apparel, and teamwear, catering to both casual and athletic needs. Additionally, Hanesbrands licenses its Champion brand for footwear and sports accessories, further expanding its market reach.
With a brand portfolio that includes Hanes, Champion, Maidenform, and others, Hanesbrands commands a strong position in the market. These brands are distributed through a variety of channels, including retailers, wholesalers, and third-party embellishers, ensuring broad accessibility. This diverse brand strategy allows the company to cater to a wide demographic, from everyday essentials to premium products.
Headquartered in Winston-Salem, North Carolina, Hanesbrands operates with a global outlook, leveraging its international segment to tap into growing markets. This strategic approach underscores its commitment to meeting consumer needs worldwide, supported by a robust supply chain and brand recognition.
From a financial perspective, Hanesbrands boasts a market capitalization of approximately $2.2 billion, with a forward P/E ratio of 11.31, signaling investor confidence in future growth. The price-to-sales ratio of 0.63 may indicate a valuation consideration, while the high price-to-book ratio of 64.78 warrants attention. These metrics, coupled with the companys
Additional Sources for HBI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HBI Stock Overview
Market Cap in USD | 2,168m |
Sector | Consumer Cyclical |
Industry | Apparel Manufacturing |
GiC Sub-Industry | Apparel, Accessories & Luxury Goods |
IPO / Inception | 2006-09-06 |
HBI Stock Ratings
Growth 5y | -35.2% |
Fundamental | -60.0% |
Dividend | 9.12% |
Rel. Strength Industry | 8.76 |
Analysts | 3/5 |
Fair Price Momentum | 5.81 USD |
Fair Price DCF | 11.91 USD |
HBI Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 72.1% |
HBI Growth Ratios
Growth Correlation 3m | -71.8% |
Growth Correlation 12m | 84% |
Growth Correlation 5y | -68.5% |
CAGR 5y | -13.02% |
CAGR/Max DD 5y | -0.16 |
Sharpe Ratio 12m | 0.71 |
Alpha | 17.24 |
Beta | 0.70 |
Volatility | 75.52% |
Current Volume | 6819.9k |
Average Volume 20d | 7957.7k |
As of February 22, 2025, the stock is trading at USD 6.14 with a total of 6,819,855 shares traded.
Over the past week, the price has changed by +4.42%, over one month by -26.29%, over three months by -25.03% and over the past year by +34.06%.
No, based on ValueRay Fundamental Analyses, Hanesbrands (NYSE:HBI) is currently (February 2025) a stock to sell. It has a ValueRay Fundamental Rating of -60.01 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HBI as of February 2025 is 5.81. This means that HBI is currently overvalued and has a potential downside of -5.37%.
Hanesbrands has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold HBI.
- Strong Buy: 1
- Buy: 1
- Hold: 3
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, HBI Hanesbrands will be worth about 6.4 in February 2026. The stock is currently trading at 6.14. This means that the stock has a potential upside of +3.91%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7.8 | 26.4% |
Analysts Target Price | 8.2 | 33.4% |
ValueRay Target Price | 6.4 | 3.9% |